PodParley PodParley
PodParley
Can Tirzepatide (Mounjaro™️) Really Help with Weight Loss? episode artwork

EPISODE · Jul 14, 2022 · 15 MIN

Can Tirzepatide (Mounjaro™️) Really Help with Weight Loss?

from The Scope

In Spring 2022, the FDA approved tirzepatide to help control insulin for patients with Type 2 Diabetes. Yet news stories were more focused on a secondary effect of the drug, known by the brand name Mounjaro™️: significant weight loss with just a weekly injection. Juliana Simonetti, MD, co-director of the Comprehensive Weight Management Program at University of Utah Health, explains how this new drug works and its potential for weight management if it were to be approved for that use.

Episode metadata supplied by the publisher feed · Published Jul 14, 2022

Embed this episode

NOW PLAYING

Can Tirzepatide (Mounjaro™️) Really Help with Weight Loss?

0:00 15:38

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Scope?

This episode is 15 minutes long.

When was this The Scope episode published?

This episode was published on July 14, 2022.

Can I download this The Scope episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!